Endothelin antagonists ii

Details Endothelin antagonists ii Endothelin antagonists ii

C - Chemistry, Metallurgy

07

K

C07K 7/06 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) C07K 5/04 (2006.01) C07K 14/575 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2133090

2133090 9321219 PCTABS00027 Novel antagonists of endothelin are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, metabolic, endocrinological, neurological disorders, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, atherosclerotic disorders including Raynaud's disease, restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, ischemic bowel disease, and diabetes. In the claimed new compounds, the N-terminal 16-His is replaced by a building-block of formula (.alpha.).

Affiliated with

Also associated with

Rating

Endothelin antagonists ii does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Endothelin antagonists ii, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists ii will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1358253